Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Loss from continuing operations	$ (83,624)	$ (140,817)
Less: Loss from discontinued operations, net of tax	(256)	(12,454)
Net loss from continuing operations	(83,368)	(128,363)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,842	11,356
Stock-based compensation	13,688	17,427
Amortization of debt discount	623	600
Deferred income tax benefit	(114)	(403)
Change in fair value of warrant liabilities	0	1,701
Amortization of right-of-use assets	667	707
Other adjustments	163	(180)
Changes in operating assets and liabilities of business, net of acquisitions:
Accounts receivable, net	2,739	674
Prepaid expenses and other assets	1,877	2,860
Prepaid sports rights	(6,731)	(20,413)
Accounts payable	(4,974)	(6,706)
Accrued expenses and other liabilities	(11,569)	2,210
Deferred revenue	1,048	(1,297)
Lease liabilities	70	628
Net cash used in operating activities - continuing operations	(77,039)	(119,199)
Net cash used in operating activities - discontinued operations	(1,150)	(5,676)
Net cash used in operating activities	(78,189)	(124,875)
Cash flows from investing activities
Purchases of property and equipment	(102)	(798)
Capitalization of internal use software	(3,816)	(1,026)
Net cash used in investing activities - continuing operations	(3,918)	(1,824)
Net cash used in investing activities - discontinued operations	0	(4,071)
Net cash used in investing activities	(3,918)	(5,895)
Cash flows from financing activities
Proceeds from the issuance of common stock / At-the-Market offering, net of offering costs	106,130	203,765
Redemption of non-controlling interest	(2,147)	0
Vested restricted stock units settled for cash	(125)	0
Proceeds from exercise of stock options	46	443
Proceeds from the exercise of warrants	0	5,000
Repayments of notes payable and long-term borrowings	(217)	0
Net cash provided by financing activities - continuing operations	103,687	209,208
Net cash provided by financing activities - discontinued operations	0	0
Net cash provided by financing activities	103,687	209,208
Net increase in cash, cash equivalents and restricted cash	21,580	78,438
Cash, cash equivalents and restricted cash at beginning of period	343,226	376,080
Cash, cash equivalents and restricted cash at end of period	364,806	454,518
Supplemental disclosure of cash flows information:
Interest paid	6,550	6,647
Income taxes paid	6	0
Non-cash financing and investing activities:
Shares settled liability	1,825	0
Reclassification of the equity components of the 2026 Convertible Notes to liability upon adoption of ASU 2020-06	0	75,264
Cashless exercise of warrants	0	5,249
Accrued expenses - At-the-Market offering	$ 91	$ 19